Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jul 26, 2022; 10(21): 7495-7501
Published online Jul 26, 2022. doi: 10.12998/wjcc.v10.i21.7495
Published online Jul 26, 2022. doi: 10.12998/wjcc.v10.i21.7495
Successful treatment of hyperglycemia with liraglutide in a hospitalized 27-year-old patient with schizophrenia: A case report
Lei Zhang, Wen-Juan Yu, Hua-Fang Li, Department of Psychiatry, Shanghai Mental Health Center, Shanghai 200030, China
Lei Zhang, Wen-Juan Yu, Hui Zhu, Hua-Fang Li, Jie Qiao, School of Medicine, Shanghai Jiaotong University, Shanghai 200025, China
Hui Zhu, Jie Qiao, Department of Endocrinology, Shanghai Jiaotong University School of Medicine, Shanghai 9th Hospital, Shanghai 200011, China
Author contributions: Zhang L performed the disease consultation, acquired the clinical data, and drafted the manuscript; Yu WJ and Zhu H reviewed the literature; Qiao J and Li HF edited and reviewed the manuscript.
Supported by the National Natural Science Foundation of China , No. 81873652 ; and the Programs Foundation of Shanghai Mental Health Center , China, No. 2020-QH-03.
Informed consent statement: Informed written consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Jie Qiao, MD, PhD, Chief Doctor, Department of Endocrinology, Shanghai Jiaotong University School of Medicine, Shanghai 9th Hospital, No. 369 Zhizaoju Road, Shanghai 200011, China. qiaoj2001@126.com
Received: December 30, 2021
Peer-review started: December 30, 2021
First decision: February 8, 2022
Revised: February 24, 2022
Accepted: June 3, 2022
Article in press: June 3, 2022
Published online: July 26, 2022
Processing time: 192 Days and 16.4 Hours
Peer-review started: December 30, 2021
First decision: February 8, 2022
Revised: February 24, 2022
Accepted: June 3, 2022
Article in press: June 3, 2022
Published online: July 26, 2022
Processing time: 192 Days and 16.4 Hours
Core Tip
Core Tip: This report describes the effects of GLP-1 receptor agonist treatment in a young schizophrenia patient with long-term use of antipsychotics, which induced type 2 diabetes. It presents the success of blood glucose control with the GLP-1 receptor agonist in a short period of time during his hospitalization and helped him to control his blood glucose and lose weight while maintaining a stable mental status in the long-term.